STAAR Surgical Company Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 2 | $0.06 | $0.07 | $0.06 |
| Q2 2024 | 2 | $0.24 | $0.24 | $0.24 |
| Q3 2024 | 3 | $0.18 | $0.18 | $0.18 |
| Q4 2024 | 6 | -$0.09 | $0.05 | -$0.03 |
| Q1 2025 | 6 | $0.07 | $0.14 | $0.10 |
| Q2 2025 | 3 | $0.35 | $0.39 | $0.37 |
| Q3 2025 | 3 | $0.27 | $0.30 | $0.29 |
| Q4 2025 | 3 | $0.13 | $0.15 | $0.14 |
| Q1 2026 | 2 | $0.05 | $0.05 | $0.05 |
| Q2 2026 | 2 | $0.39 | $0.45 | $0.42 |
| Q3 2026 | 2 | $0.33 | $0.37 | $0.35 |
| Q4 2026 | 2 | $0.10 | $0.12 | $0.11 |
STAAR Surgical Company Earnings Date And Information
STAAR Surgical Company last posted its earnings results on Wednesday, October 30th, 2024. The company reported $0.41 earnings per share for the quarter, topping analysts' consensus estimates of $0.19 by $0.22. The company had revenue of 88.59 M for the quarter and had revenue of 322.42 M for the year. STAAR Surgical Company has generated $0 earnings per share over the last year ($0.43 diluted earnings per share) and currently has a price-to-earnings ratio of 60.87. STAAR Surgical Company has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 19th, 2025 based on prior year's report dates.
STAAR Surgical Company Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 10/30/2024 | Q3 2024 | $0.19 | $0.20 | 0.01 | $86.90 M | $88.59 M |
| 08/07/2024 | Q2 2024 | $0.25 | $0.15 | -0.1 | $99.01 M | |
| 05/07/2024 | Q1 2024 | $0.05 | -$0.07 | -0.12 | $77.36 M | |
| 02/27/2024 | Q4 2023 | $0.16 | $76.27 M | |||
| 11/06/2023 | Q3 2023 | $0.10 | $80.31 M | |||
| 08/02/2023 | Q2 2023 | $0.32 | $0.13 | -0.19 | $92.31 M | |
| 05/03/2023 | Q1 2023 | $0.11 | $0.06 | -0.05 | $73.53 M | |
| 02/22/2023 | Q4 2022 | $0.12 | $64.04 M | |||
| 11/02/2022 | Q3 2022 | $0.21 | $0.21 | 0 | $76.05 M | |
| 08/10/2022 | Q2 2022 | $0.25 | $0.27 | 0.02 | $81.10 M | |
| 05/04/2022 | Q1 2022 | $0.16 | $0.20 | 0.04 | $63.20 M | |
| 02/23/2022 | Q4 2021 | $0.16 | $0.10 | -0.06 | $59.00 M | |
| 11/03/2021 | Q3 2021 | $0.16 | $0.13 | -0.03 | $58.35 M | |
| 08/04/2021 | Q2 2021 | $0.08 | $0.18 | 0.1 | $62.37 M | |
| 05/05/2021 | Q1 2021 | $0.01 | $0.11 | 0.1 | $50.75 M | |
| 02/24/2021 | Q4 2020 | $0.09 | $0.07 | -0.02 | $46.00 M | |
| 11/04/2020 | Q3 2020 | $0.09 | $0.08 | -0.01 | $47.08 M | |
| 08/05/2020 | Q2 2020 | $0.02 | -$0.03 | -0.05 | $35.19 M | |
| 05/06/2020 | Q1 2020 | $0.02 | -$0.00 | -0.02 | $35.19 M | |
| 02/26/2020 | Q4 2019 | $0.05 | $0.14 | 0.09 | $38.88 M |
STAAR Surgical Company Earnings: Frequently Asked Questions
-
When is STAAR Surgical Company's earnings date?
STAAR Surgical Company has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 19th, 2025 based off last year's report dates.
-
Did STAAR Surgical Company beat their earnings estimates last quarter?
In the previous quarter, STAAR Surgical Company (:STAA) reported $0.41 earnings per share (EPS) to beat the analysts' consensus estimate of $0.19 by $0.22.
-
How can I listen to STAAR Surgical Company's earnings conference call?
The conference call for STAAR Surgical Company's latest earnings report can be listened to online.
-
How can I read STAAR Surgical Company's conference call transcript?
The conference call transcript for STAAR Surgical Company's latest earnings report can be read online.
-
How much revenue does STAAR Surgical Company generate each year?
STAAR Surgical Company (:STAA) has a recorded annual revenue of $322.42 M.
-
How much profit does STAAR Surgical Company generate each year?
STAAR Surgical Company (:STAA) has a recorded net income of $322.42 M. STAAR Surgical Company has generated $0.44 earnings per share over the last four quarters.
-
What is STAAR Surgical Company's price-to-earnings ratio?
STAAR Surgical Company (:STAA) has a price-to-earnings ratio of 60.87 and price/earnings-to-growth ratio is 2.07.
